Patents/Assignees

TRAWS PHARMA, Inc.

1 patent in portfolio

US12156856utility2024
Formulation of (e)-2,4,6-trimethoxystyryl-3-[(carboxymethyl)amino]-4-methoxybenzylsulphone with Enhanced Stability and Bioavailability
0 cites